
Peter M. Poon
Supervisory Patent Examiner (ID: 4674, Phone: (571)272-6891 , Office: P/3643 )
| Most Active Art Unit | 3103 |
| Art Unit(s) | 3613, 3644, 3643, 3103 |
| Total Applications | 881 |
| Issued Applications | 571 |
| Pending Applications | 64 |
| Abandoned Applications | 250 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13357291
[patent_doc_number] => 20180230185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => Peptidomimetics for Treating HER2-Overexpressd Cancer
[patent_app_type] => utility
[patent_app_number] => 15/951658
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15951658
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/951658 | Peptidomimetics for Treating HER2-Overexpressd Cancer | Apr 11, 2018 | Abandoned |
Array
(
[id] => 13339827
[patent_doc_number] => 20180221453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => Articular Cartilage Mimetics
[patent_app_type] => utility
[patent_app_number] => 15/947098
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947098
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947098 | Articular Cartilage Mimetics | Apr 5, 2018 | Abandoned |
Array
(
[id] => 13461661
[patent_doc_number] => 20180282373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => PEPTIDE-BASED INHIBITORS OF MLL/SET1 FAMILY CORE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 15/939604
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15939604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/939604 | Peptide-based inhibitors of MLL/SET1 family core complexes | Mar 28, 2018 | Issued |
Array
(
[id] => 13371911
[patent_doc_number] => 20180237496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => ENGINEERED POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 15/934744
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934744
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/934744 | Engineered polypeptides | Mar 22, 2018 | Issued |
Array
(
[id] => 12217555
[patent_doc_number] => 20180055914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'STABLE PHARMACEUTICAL FORMULATION COMPRISING A RECONSTITUTED PULMONARY SURFACTANT COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/683822
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5413
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15683822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/683822 | Stable pharmaceutical formulation comprising a reconstituted pulmonary surfactant composition | Aug 22, 2017 | Issued |
Array
(
[id] => 12975883
[patent_doc_number] => 20170340711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => Articular Cartilage Mimetics
[patent_app_type] => utility
[patent_app_number] => 15/674160
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674160 | Articular Cartilage Mimetics | Aug 9, 2017 | Abandoned |
Array
(
[id] => 13899091
[patent_doc_number] => 20190038750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => TRIPLE ANTIBIOTIC CATIONIC OINTMENT
[patent_app_type] => utility
[patent_app_number] => 15/669886
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15669886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/669886 | TRIPLE ANTIBIOTIC CATIONIC OINTMENT | Aug 3, 2017 | Abandoned |
Array
(
[id] => 12126256
[patent_doc_number] => 20180009842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Arginine-rich Peptide Mixture, their Application Thereof in Cervical Cancer Therapy, and a Process for Producing same'
[patent_app_type] => utility
[patent_app_number] => 15/642278
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6399
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15642278
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/642278 | Arginine-rich Peptide Mixture, their Application Thereof in Cervical Cancer Therapy, and a Process for Producing same | Jul 4, 2017 | Abandoned |
Array
(
[id] => 14452519
[patent_doc_number] => 10322206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Compositions and methods for wound healing
[patent_app_type] => utility
[patent_app_number] => 15/472330
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17557
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472330
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472330 | Compositions and methods for wound healing | Mar 28, 2017 | Issued |
Array
(
[id] => 11821840
[patent_doc_number] => 20170210777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'ANTIBODY-BINDING POLYPEPTIDE, ANTIBODY-BINDING FUSION POLYPEPTIDE, AND ADSORPTION MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 15/469660
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15597
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/469660 | Antibody-binding polypeptide, antibody-binding fusion polypeptide, and adsorption material | Mar 26, 2017 | Issued |
Array
(
[id] => 15008463
[patent_doc_number] => 10450347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Immunomodulators
[patent_app_type] => utility
[patent_app_number] => 15/465218
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49827
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/465218 | Immunomodulators | Mar 20, 2017 | Issued |
Array
(
[id] => 11948307
[patent_doc_number] => 20170252459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'MULTIVALENT FIBRONECTIN-INTEGRIN BINDING COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/448772
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7252
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448772
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448772 | Multivalent fibronectin-integrin binding compositions and methods of use thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 12997549
[patent_doc_number] => 10022420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Methods of synthesizing g-AApeptides, g-AApeptide building blocks, g-AApeptide libraries, and g-AApeptide inhibitors of Ab
[patent_app_type] => utility
[patent_app_number] => 15/438932
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 34
[patent_no_of_words] => 14561
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15438932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/438932 | Methods of synthesizing g-AApeptides, g-AApeptide building blocks, g-AApeptide libraries, and g-AApeptide inhibitors of Ab | Feb 21, 2017 | Issued |
Array
(
[id] => 12367290
[patent_doc_number] => 09957298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Peptides as oxytocin agonists
[patent_app_type] => utility
[patent_app_number] => 15/368080
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4492
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15368080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/368080 | Peptides as oxytocin agonists | Dec 1, 2016 | Issued |
Array
(
[id] => 14119583
[patent_doc_number] => 10246641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Processes for producing hydrocarbon products
[patent_app_type] => utility
[patent_app_number] => 15/332654
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 97415
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332654 | Processes for producing hydrocarbon products | Oct 23, 2016 | Issued |
Array
(
[id] => 11401724
[patent_doc_number] => 20170022262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'CRYSTALLINE INSULIN-CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 15/288362
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 45396
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/288362 | CRYSTALLINE INSULIN-CONJUGATES | Oct 6, 2016 | Abandoned |
Array
(
[id] => 11323907
[patent_doc_number] => 20160354518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'BONE PASTES COMPRISING BIOFUNCTIONALIZED CALCIUM PHOSPHATE CEMENTS WITH ENHANCED CELL FUNCTIONS FOR BONE REPAIR'
[patent_app_type] => utility
[patent_app_number] => 15/241950
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16881
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/241950 | BONE PASTES COMPRISING BIOFUNCTIONALIZED CALCIUM PHOSPHATE CEMENTS WITH ENHANCED CELL FUNCTIONS FOR BONE REPAIR | Aug 18, 2016 | Abandoned |
Array
(
[id] => 11455783
[patent_doc_number] => 20170049689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'ACTIVE COMBINATIONS, COMPOSITIONS AND METHODS FOR ENHANCING HAIR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 15/241506
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10004
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15241506
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/241506 | ACTIVE COMBINATIONS, COMPOSITIONS AND METHODS FOR ENHANCING HAIR GROWTH | Aug 18, 2016 | Abandoned |
Array
(
[id] => 11602544
[patent_doc_number] => 20170119844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'HEMOSTATIC PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/128802
[patent_app_country] => US
[patent_app_date] => 2016-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11755
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15128802
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/128802 | HEMOSTATIC PHARMACEUTICAL COMPOSITION | Aug 5, 2016 | Abandoned |
Array
(
[id] => 11289148
[patent_doc_number] => 20160339081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'Peptide Pharmaceutical for Oral Delivery'
[patent_app_type] => utility
[patent_app_number] => 15/174417
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10740
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174417 | Peptide Pharmaceutical for Oral Delivery | Jun 5, 2016 | Abandoned |